Table 3.
MHC class II allele distribution of the MG patients and controls
| HLA allele | Patients | Controls | p value |
|---|---|---|---|
| DRB1*01 | 12 (11.1) | 20 (8.0) | NS |
| DRB1*03 | 21 (19.4) | 40 (16.0) | NS |
| DRB1*04 | 22 (20.4) | 76 (30.4) | NS |
| DRB1*07 | 18 (16.7) | 41 (16.4) | NS |
| DRB1*08 | 7 (6.5) | 12 (4.8) | NS |
| DRB1*09 | 3 (2.8) | 6 (2.4) | NS |
| DRB1*10 | 5 (4.6) | 14 (5.6) | NS |
| DRB1*11 | 45 (41.7) | 81 (32.4) | NS |
| DRB1*12 | 3 (2.8) | 8 (3.2) | NS |
| DRB1*13 | 17 (15.7) | 57 (22.8) | NS |
| DRB1*14 | 18 (16.7) | 25 (10.0) | NS |
| DRB1*15 | 26 (24.1) | 55 (22.0) | NS |
| DRB1*16 | 6 (5.6) | 26 (10.4) | NS |
| DQB1*02 | 32 (29.6) | 59 (23.6) | NS |
| DQB1*03 | 65 (60.2) | 171 (68.4) | NS |
| DQB1*04 | 6 (5.6) | 11 (4.4) | NS |
| DQB1*05 | 41 (38.0) | 93 (37.2) | NS |
| DQB1*06 | 36 (33.3) | 76 (30.4) | NS |
Values are presented as numbers (%) unless otherwise stated. MHC, major histocompatibility complex; MG, myasthenia gravis; NS, not significant.